That is very important, since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (future report). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. This was a development practically nobody observed. But it's going to have profound ramifications for treating disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (last week). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps substantially prior to going greater - black sea. I've been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly informing readers. But that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown tech stock 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of fantastic personal business on the brink of striking the public markets And I've been dealing with a brand-new method for you to invest even prior to these companies go public.
This chance has been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the information. Go right here to reserve your spot for totally free.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our usual beat (jeff brown biotech picks). And when it comes to tech investing, we leave it to the specialists. Thankfully, we have several such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (what is the legacy report predicting). In truth, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and predict what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing exponential development and creating unbelievable chances for financiers. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. jeff brown 2021 stock predictions. But regardless of what lots of readers might think, this is a trend that's simply getting begun. Although the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown latest prediction). Losing 2 months of production and sales truly affects the number of 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million systems is exceptional. More notably, the hold-ups caused by the pandemic created a lots of suppressed demand. Which demand is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - black sea. And that's not my only 5G forecast When I've talked about 5G in the past, I have actually explained its 3 different phases.
In Phase 2, 5G devices go on sale. 5G phones and other products start to reach customers. And in Stage 3, 5G services begin to be used (what is the legacy report predicting). That's when we begin to see applications working on 5G networks. Believe of things like massive multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer. This begins something of a virtuous cycle: A lot of individuals do not actually care about the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In truth, 5G is going to open a suite of incredible applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities moving forward will be enormous. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not operate properly. CRISPR utilizes a comparable idea but with our genetic code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And throughout that time, there were really only 3 companies running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with illness and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing unbelievable returns. This entire market is efficiently a greenfield chance.
There's room for many companies to exist in this space. jeff brown biotech stock pick for 2020. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or 3 more hereditary modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can precisely predict the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That's crucial because the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental procedure. And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug therapies produced using this innovation. This was among those breakthroughs that nearly no one saw. However it's going to have extensive ramifications for curing illness. And, of course, there will be plenty of investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it drew back perhaps significantly prior to going higher. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever published was on bitcoin - jeff brown biotech picks. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. tech stocks. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the info is up to date since February 2021, but we might not individually verify this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to pick winning technology stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent point of view on the market. He's always on the hunt for brand-new opportunities, and he shares a number of his finest choices in the Near Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an excellent reputation as a stock-picker, and he successfully anticipated some of the biggest economic occasions of the previous 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. No one on Wall Street gets it right whenever, but Jeff Brown's precise predictions have earned him legions of devoted followers. That says a lot about his ability. The Near Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research provides a number of research study services with a broad variety of specializations - biotech stock.
The company is likewise associated with Bonner & Partners, another well-respected research publisher - jeff brown 2021 predictions. On its website, Brownstone says its mission is to supply retail investors with professional-grade research study: "For too long, the very best investment research has actually not been offered to private financiers. It has actually been generally booked for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown 2021 stock picks. The objective of Brownstone Research study is to make that type of proprietary research readily available to any financiers aiming to acquire an edge in the markets. The goal is easy to deliver unique and lucrative financial investment research study found no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also acts as the firm's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. exponential growth. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In truth, Brown believes S.A.V. jeff brown 1 biotech company. could be "the greatest pattern of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two innovative technologies: artificial intelligence and electrical vehicles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars ever. It's absolutely nothing brief of the vehicle market's Holy Grail. As you understand, electrical automobiles and self-driving vehicle stocks have actually been huge this year, however the Wall Street device has been huge on buzz without much tangible outcome. Regardless of an extreme increase in competitors over the previous couple of years, Brown still believes Musk has the very best chance of putting everything together.
tech might be the magic string that connects all of it together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transportation. Basically, this innovation would allow you to rent your vehicle as an autonomous, self-driving taxi when you're not using it. You simply get out of the automobile and press a button on an app that tells the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your sofa while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the revenues. It sounds outrageous, but it might be closed than you believe.